Latest News

The news items below include announcements from companies in the Brain Tumor Investment Fund™ portfolio. These announcements are produced by the companies themselves. Their content, including any forward-looking or investigational claims, is the responsibility of the issuing company. Brain Tumor Investment Fund™ and National Brain Tumor Society do not specifically endorse or verify third-party statements, and investigational therapies referenced have not been proven safe or effective and are not approved by the U.S. Food and Drug Administration.